Further, increased IGFBP3 expression has also been linked to renal cell carcinoma [27], breast cancer [31,49], and metastatic melanoma [50], suggesting that IGFBP3 may contribute to tumorigenesis or disease progression. This evidence concerns the gene IGFBP3 and breast cancer.